Literature DB >> 21199902

Managing bloodstream infections in patients who have short-term central venous catheters.

Naomi P O'Grady1, Daniel S Chertow.   

Abstract

Catheter-related bloodstream infections can be complicated to manage, but a growing body of evidence supports specific recommendations. In 2009, the Infectious Diseases Society of America published updated guidelines for the diagnosis and management of all intravascular catheter-related infections. Here we provide a focused review on the management of bloodstream infections in adult patients with short-term (not surgically implanted and not tunneled) central venous catheters, including peripherally inserted central catheters. This review should serve as a ready reference for providers (eg, hospitalists, surgeons, physician assistants, nurse practitioners, intensivists) managing adult patients with short-term central venous catheters in place.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21199902     DOI: 10.3949/ccjm.77a.10015

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  4 in total

Review 1.  Early removal versus expectant management of central venous catheters in neonates with bloodstream infection.

Authors:  Chakrapani Vasudevan; Sam J Oddie; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

2.  Should central venous catheter be systematically removed in patients with suspected catheter related infection?

Authors:  Leonardo Lorente; María M Martín; Pablo Vidal; Sergio Rebollo; María I Ostabal; Jordi Solé-Violán
Journal:  Crit Care       Date:  2014-10-17       Impact factor: 9.097

3.  In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions.

Authors:  Diego Parra; Alejandro Peña-Monje; Nieves María Coronado-Álvarez; José Hernández-Quero; Jorge Parra-Ruiz
Journal:  BMC Microbiol       Date:  2015-10-30       Impact factor: 3.605

4.  A vascular access and midlines program can decrease hospital-acquired central line-associated bloodstream infections and cost to a community-based hospital.

Authors:  Rahul Pathak; Sumalatha Gangina; Falina Jairam; Kimberly Hinton
Journal:  Ther Clin Risk Manag       Date:  2018-08-21       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.